四川
分享至
摘要：生物医药行业正处在估值调整、产业整合并行的周期窗口，不少企业收缩战线保守观望，而康华生物选择双线同步发力，
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
